- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04408157
A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic (SWitCh)
A Research Study to Evaluate the Efficacy of a Self-management Booklet (Stay Well During COVID-19; SWitCh) to Promote Wellbeing During the COVID-19 Pandemic
Background The immediate psychological impact of COVID-19 is already emerging. The investigators are interested in the benefits of a self-management booklet focused on the current circumstances in response to the COVID-19 pandemic on people's physical and mental wellbeing.
Who can participate? The investigators are looking for participants aged 18 and over who live in the UK and can read and write in English, without any current serious mental health problems (e.g. bipolar disorder, PTSD, active thoughts of self-harm, or severe anxiety/depression), and who feel that their physical and/or mental wellbeing have been affected since the COVID-19 pandemic.
What does the study involve? Eligible participants will complete questionnaires at baseline following which they will be randomly allocated to either receive the self-management booklet right away (via email) or after 4 months (waiting-list, in the meantime participants will be provided a link to educational materials). Participants will not be able to choose whether they will receive the self-management booklet right away or be in the waiting-list as a computer system (Qualtrics randomiser) will allocate them to one of the two groups at random. Participants in both conditions will be asked to complete online questionnaires at multiple time points, 2-months and 4-months after allocation. Participants in the waiting-list condition will also be asked to complete the same set of questionnaires at 6- and 8-months after allocation to assess how beneficial they found the self-management booklet.
Participants will also be invited to take part in an audio-recorded interview after T2 to tell us more about how they found the self-management booklet or the educational materials. The investigators will select 30 participants (15 from each condition) for the interview out of those who opt-in to capture a wide range of experiences and backgrounds.
What are the possible benefits and risks of participating? Risks to participants are small. Participants may find reflecting on the impact of COVID-19 on their lives distressing. However, these effects are anticipated to be short lived, as participants will learn psychological techniques during the intervention that can help them manage better in the current circumstances and improve their wellbeing.
Where is the study run from? The lead site is King's College London. The study is run online via Qualtrics.
When is the study starting and how long is it expected to run for? May 2020 to May 2021
Who is the main contact? Dr Federica Picariello federica.picariello@kcl.ac.uk
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom
- Online recruitment through Qualtrics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged 18 and over who live in the UK and can read and write in English, without any current serious mental health problems (e.g. bipolar disorder, PTSD, active thoughts of self-harm, or severe anxiety/depression) and who feel that their physical and/or mental wellbeing have been affected since the COVID-19 pandemic.
Exclusion Criteria:
- Any current serious mental health problems (e.g. bipolar disorder, PTSD, active thoughts of self-harm, or severe anxiety/depression) or who feel that their physical and/or mental wellbeing have not been affected by COVID-19
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Self-management booklet
Self-management booklet: developed drawing on existing evidence and work conducted by researchers at the Health Psychology section at KCL, tailored to the current circumstances in response to the COVID-19 pandemic.
|
The purpose of this booklet is to support adjustment to the current circumstances of the COVID-19 pandemic and facilitate the development and maintenance of healthy behaviours at home.
The booklet covers a range of topics, including understanding bodily sensations and symptoms of COVID-19, managing the uncertainty surrounding COVID-19, physical activity, sedentary behaviour, sleep, social support and isolation, nutrition and alcohol consumption, sex and intimate relationships, and coping with children at home.
The booklet will provide structured guidance on the various topics through the use of effective behaviour change techniques, in particular self-monitoring, goal setting, and problem solving and signposting to additional helpful resources, such as drinking or nutrition tracking apps.
|
|
No Intervention: Education only (waiting-list)
Participants allocated to the waiting-list control arm will receive a link via email to educational materials related to COVID produced by King's College London for an online event and will be provided with the self-management booklet after completing the T2 assessment and qualitative interview.
The topics covered in the online event are the same as the ones included in the self-management booklet, without structured guidance and behaviour change techniques to facilitate behaviour change.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS): Tennant et al., 2007
Time Frame: 2 months post-randomisation
|
validated self-report measure; scores range from 14 to 70 and higher scores indicate greater positive mental wellbeing.
|
2 months post-randomisation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS): Tennant et al., 2007
Time Frame: 4 months post-randomisation
|
validated self-report measure; scores range from 14 to 70 and higher scores indicate greater positive mental wellbeing.
|
4 months post-randomisation
|
|
Self-rated health status: Bombak, 2013
Time Frame: 2 months post-randomisation
|
validated self-report measure; scores range from 0 to 100 and higher scores indicate better health
|
2 months post-randomisation
|
|
Self-rated health status: Bombak, 2013
Time Frame: 4 months post-randomisation
|
validated self-report measure; scores range from 0 to 100 and higher scores indicate better health
|
4 months post-randomisation
|
|
Brief Resilience Scale (BRS): Smith et al., 2008
Time Frame: 2 months post-randomisation
|
validated self-report measure; items are averaged to create a total score, ranging from 1 to 7 and higher total scores indicate higher levels of resilience.
|
2 months post-randomisation
|
|
Brief Resilience Scale (BRS): Smith et al., 2008
Time Frame: 4 months post-randomisation
|
validated self-report measure; items are averaged to create a total score, ranging from 1 to 7 and higher total scores indicate higher levels of resilience.
|
4 months post-randomisation
|
|
Intolerance of Uncertainty Scale (IUS-12): Carleton et al., 2007
Time Frame: 2 months post-randomisation
|
validated self-report measure; total scores range from 12 to 60 and higher scores indicate higher intolerance of uncertainty
|
2 months post-randomisation
|
|
Intolerance of Uncertainty Scale (IUS-12): Carleton et al., 2007
Time Frame: 4 months post-randomisation
|
validated self-report measure; total scores range from 12 to 60 and higher scores indicate higher intolerance of uncertainty
|
4 months post-randomisation
|
|
Positive Affect subscale of the Positive and Negative Affect Scale-X (PANAS-X): Watson & Clark, 1999
Time Frame: 2 months post-randomisation
|
validated self-report measure; positive affect items (N=27) are rated on a five-point scale (1) very slightly or not at all, (2) a little, (3) moderately, (4) quite a bit, and (5) extremely and can be grouped into subscales according to Watson, D., & Clark, L. A. (1999).
The PANAS-X: Manual for the positive and negative affect schedule-expanded form.
Higher scores indicate higher levels of positive affect states.
|
2 months post-randomisation
|
|
Positive Affect subscale of the Positive and Negative Affect Scale-X (PANAS-X): Watson & Clark, 1999
Time Frame: 4 months post-randomisation
|
validated self-report measure; positive affect items (N=27) are rated on a five-point scale (1) very slightly or not at all, (2) a little, (3) moderately, (4) quite a bit, and (5) extremely and can be grouped into subscales according to Watson, D., & Clark, L. A. (1999).
The PANAS-X: Manual for the positive and negative affect schedule-expanded form.
Higher scores indicate higher levels of positive affect states.
|
4 months post-randomisation
|
|
UCLA 3 item loneliness scale: Russell, 1996
Time Frame: 2 months post-randomisation
|
validated self-report measure; total scores range from 3 to 9 and higher scores indicate higher levels of loneliness
|
2 months post-randomisation
|
|
UCLA 3 item loneliness scale: Russell, 1996
Time Frame: 4 months post-randomisation
|
validated self-report measure; total scores range from 3 to 9 and higher scores indicate higher levels of loneliness
|
4 months post-randomisation
|
|
Multidimensional Scale of Perceived Social Support (MSPSS): Zimet et al., 1988
Time Frame: 2 months post-randomisation
|
validated self-report measure; the scale consists of three subscales (family, friends, and significant other) that contain 4 items each; each subscale score can range from 4 to 28.
Items are summed, and a total score is also calculated and ranges from 12 to 84.
Higher subscale and total scores indicate higher levels of perceived social support.
|
2 months post-randomisation
|
|
Multidimensional Scale of Perceived Social Support (MSPSS): Zimet et al., 1988
Time Frame: 4 months post-randomisation
|
validated self-report measure; the scale consists of three subscales (family, friends, and significant other) that contain 4 items each; each subscale score can range from 4 to 28.
Items are summed, and a total score is also calculated and ranges from 12 to 84.
Higher subscale and total scores indicate higher levels of perceived social support.
|
4 months post-randomisation
|
|
Subjective Health Complaint Scale (SHC): Eriksen, Ihlebæk, & Ursin, 1999
Time Frame: 2 months post-randomisation
|
validated self-report measure; a total score will be obtained for each symptom (severity x duration) with a possible range from 0 to 90, with higher scores indicating greater severity of a symptom, total number of symptoms reported, and a total score from 0 to 84 with higher scores indicating greater severity of somatic complaints.
|
2 months post-randomisation
|
|
Subjective Health Complaint Scale (SHC): Eriksen, Ihlebæk, & Ursin, 1999
Time Frame: 4 months post-randomisation
|
validated self-report measure; a total score will be obtained for each symptom (severity x duration) with a possible range from 0 to 90, with higher scores indicating greater severity of a symptom, total number of symptoms reported, and a total score from 0 to 84 with higher scores indicating greater severity of somatic complaints.
|
4 months post-randomisation
|
|
Leeds Sleep Evaluation Questionnaire (LSEQ): Parrott & Hindmarch, 1980
Time Frame: 2 months post-randomisation
|
validated self-report measure; responses are measured using a 100-mm scale and are then averaged to provide a score for each domain and higher scores indicate better sleep.
|
2 months post-randomisation
|
|
Leeds Sleep Evaluation Questionnaire (LSEQ): Parrott & Hindmarch, 1980
Time Frame: 4 months post-randomisation
|
validated self-report measure; responses are measured using a 100-mm scale and are then averaged to provide a score for each domain and higher scores indicate better sleep.
|
4 months post-randomisation
|
|
Self-reported napping: Stone et al., 2018
Time Frame: 2 months post-randomisation
|
self-report measure used in Stone et al., 2018; self-reported napping is defined as reporting at least 1 hour of napping each time and responses will be categorised as follows: no napping=coded as 0; <1 hour=coded as 1, 1-2 hours=coded as 2, and >2 hours=coded as 3.
|
2 months post-randomisation
|
|
Self-reported napping: Stone et al., 2018
Time Frame: 4 months post-randomisation
|
self-report measure used in Stone et al., 2018; self-reported napping is defined as reporting at least 1 hour of napping each time and responses will be categorised as follows: no napping=coded as 0; <1 hour=coded as 1, 1-2 hours=coded as 2, and >2 hours=coded as 3.
|
4 months post-randomisation
|
|
Work and Social Adjustment Scale (WSAS): Mundt et al., 2002
Time Frame: 2 months post-randomisation
|
validated self-report measure; total scores range from 0 to 40 and higher scores indicate greater impairment
|
2 months post-randomisation
|
|
Work and Social Adjustment Scale (WSAS): Mundt et al., 2002
Time Frame: 4 months post-randomisation
|
validated self-report measure; total scores range from 0 to 40 and higher scores indicate greater impairment
|
4 months post-randomisation
|
|
International Physical Activity Questionnaire -short form (IPAQ-SF): Craig et al., 2003
Time Frame: 2 months post-randomisation
|
validated self-report measure; The questionnaire can be scored categorically according to developed cut-offs to classify individuals into low, moderate, or high physical activity groups; or it can be scored continuously.
Responses can be converted to Metabolic Equivalent Task minutes per week (METmin/wk), according to the IPAQ scoring protocol.
MET scores across the three sub-components can be summed to indicate overall physical activity
|
2 months post-randomisation
|
|
International Physical Activity Questionnaire -short form (IPAQ-SF): Craig et al., 2003
Time Frame: 4 months post-randomisation
|
validated self-report measure; The questionnaire can be scored categorically according to developed cut-offs to classify individuals into low, moderate, or high physical activity groups; or it can be scored continuously.
Responses can be converted to Metabolic Equivalent Task minutes per week (METmin/wk), according to the IPAQ scoring protocol.
MET scores across the three sub-components can be summed to indicate overall physical activity
|
4 months post-randomisation
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
COVID-related behaviours
Time Frame: Baseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only.
|
non-validated self-report items (such as following guidelines with regards to social distancing, rated from 0 to 10 with higher scores indicating better adherence to guidelines)
|
Baseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only.
|
|
Change from baseline to follow-up on the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS): Tennant et al., 2007
Time Frame: 4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
validated self-report measure; scores range from 14 to 70 and higher scores indicate greater positive mental wellbeing.
|
4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
|
Change from baseline to follow-up on the Self-rated health status: Bombak, 2013
Time Frame: 4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
validated self-report measure; scores range from 0 to 100 and higher scores indicate better health
|
4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
|
Change from baseline to follow-up on the Brief Resilience Scale (BRS): Smith et al., 2008
Time Frame: 4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
validated self-report measure; items are averaged to create a total score, ranging from 1 to 7 and higher total scores indicate higher levels of resilience.
|
4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
|
Change from baseline to follow-up on the Intolerance of Uncertainty Scale (IUS-12): Carleton et al., 2007
Time Frame: 4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
validated self-report measure; total scores range from 12 to 60 and higher scores indicate higher intolerance of uncertainty
|
4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
|
Change from baseline to follow-up on the UCLA 3 item loneliness scale: Russell, 1996
Time Frame: 4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
validated self-report measure; total scores range from 3 to 9 and higher scores indicate higher levels of loneliness
|
4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
|
Change from baseline to follow-up on the Multidimensional Scale of Perceived Social Support (MSPSS): Zimet et al., 1988
Time Frame: 4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
validated self-report measure; the scale consists of three subscales (family, friends, and significant other) that contain 4 items each; each subscale score can range from 4 to 28.
Items are summed, and a total score is also calculated and ranges from 12 to 84.
Higher subscale and total scores indicate higher levels of perceived social support.
|
4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
|
Change from baseline to follow-up on the Leeds Sleep Evaluation Questionnaire (LSEQ): Parrott & Hindmarch, 1980
Time Frame: 4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
validated self-report measure; responses are measured using a 100-mm scale and are then averaged to provide a score for each domain and higher scores indicate better sleep.
|
4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
|
Change from baseline to follow-up on the Work and Social Adjustment Scale (WSAS): Mundt et al., 2002
Time Frame: 4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
validated self-report measure; total scores range from 0 to 40 and higher scores indicate greater impairment
|
4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
|
Change from baseline to follow-up on the International Physical Activity Questionnaire -short form (IPAQ-SF): Craig et al., 2003
Time Frame: 4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
validated self-report measure; The questionnaire can be scored categorically according to developed cut-offs to classify individuals into low, moderate, or high physical activity groups; or it can be scored continuously.
Responses can be converted to Metabolic Equivalent Task minutes per week (METmin/wk), according to the IPAQ scoring protocol.
MET scores across the three sub-components can be summed to indicate overall physical activity
|
4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
|
Change from baseline to follow-up in self-reported napping: Stone et al., 2018
Time Frame: 4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
self-report measure used in Stone et al., 2018; self-reported napping is defined as reporting at least 1 hour of napping each time and responses will be categorised as follows: no napping=coded as 0; <1 hour=coded as 1, 1-2 hours=coded as 2, and >2 hours=coded as 3.
|
4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
|
Change from baseline to follow-up on the Subjective Health Complaint Scale (SHC): Eriksen, Ihlebæk, & Ursin, 1999
Time Frame: 4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
validated self-report measure; a total score will be obtained for each symptom (severity x duration) with a possible range from 0 to 90, with higher scores indicating greater severity of a symptom, total number of symptoms reported, and a total score from 0 to 84 with higher scores indicating greater severity of somatic complaints.
|
4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
|
Change from baseline to follow-up in Positive Affect states on the Positive and Negative Affect Scale-X (PANAS-X): Watson & Clark, 1999
Time Frame: 4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
validated self-report measure; positive affect items (N=27) are rated on a five-point scale (1) very slightly or not at all, (2) a little, (3) moderately, (4) quite a bit, and (5) extremely and can be grouped into subscales according to Watson, D., & Clark, L. A. (1999).
The PANAS-X: Manual for the positive and negative affect schedule-expanded form.
Higher scores indicate higher levels of positive affect states.
|
4 months post-randomisbaseline (before randomisation), 2 and 4 months post-randomisation both arms, and 6 and 8 months post-randomisation control arm only (non-randomised comparison of change)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Federica Picariello, PhD, King's College London
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- v1.1 06.05.2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
Universidad Rey Juan CarlosNot yet recruitingPost COVID Syndrome | Long Covid | Long COVID Fatigue | Post COVID Syndrome Long Covid
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
European Institute of OncologyFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta; Azienda Ospedaliera... and other collaboratorsCompleted
-
Owlstone LtdCambridge University Hospitals NHS Foundation TrustCompleted
-
Schön Klinik Berchtesgadener LandBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID Syndrome | Post-COVID / Long-COVID | POST-Covid 19 | Post-COVID ConditionGermany
-
Erasmus Medical CenterDa Vinci Clinic; HGC RijswijkNot yet recruitingPost-COVID-19 Syndrome | Long COVID | Long Covid19 | Post COVID-19 Condition | Post-COVID Syndrome | Post COVID-19 Condition, Unspecified | Post-COVID ConditionNetherlands
-
Assiut UniversityRecruiting
-
Jilin UniversityUnknown
-
Sultan Qaboos UniversityCompletedCOVID-19 | Non-CovidOman
Clinical Trials on Self-management booklet (SWitCh: Stay well during COVID-19)
-
Universidad del DesarrolloClinica Alemana de Santiago; Clinica Indisa; Clínica BUPA; Hospital del Salvador; Hospital Regional Dr. Leonardo Guzmán de Antofagasta and other collaboratorsCompletedCovid19 | Critical Care | Postintensive Care SyndromeChile
-
University of ManitobaCompleted
-
The University of Hong KongHong Kong Council on Smoking and HealthCompleted